Effects of glucagon-like peptide-1 analogue treatment in genetic obesity: A case series.

For: All,

This case study found that liraglutide, a medication that helps with appetite and weight loss, led to meaningful weight reduction and improved quality of life in two adults with 16p11.2 deletion syndrome who struggled with therapy-resistant obesity, suggesting it may be a promising treatment option for families managing weight challenges related to this syndrome.